MBC commonly shows a triple negative breast cancer phenotype, due to the lack of expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) [5], and is managed with surgical resection in combination with radiotherapy and chemotherapy [2]. Here, ERBB2 is linked to triple-negative breast carcinoma.